Full Text View
Tabular View
No Study Results Posted
Related Studies
Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
This study is currently recruiting participants.
Verified January 2013 by Comprehensive Cancer Center of Wake Forest University
Study NCT01009983   Information provided by Comprehensive Cancer Center of Wake Forest University

First Received on November 6, 2009.   Last Updated on January 31, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
panitumumab
paclitaxel
carboplatin
laboratory biomarker analysis
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Comprehensive Cancer Center of Wake Forest University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services